Phase II trial of cisplatin (C), etoposide (E), and radiation (RT) followed by gemcitabine (G) versus G and docetaxel (D) in stage III A/B unresectable non-small cell lung cancer (NSCLC)
2008 ◽
Vol 26
(15_suppl)
◽
pp. 7597-7597
Keyword(s):
Phase Ii
◽
2015 ◽
Vol 114
(2)
◽
pp. 161-166
◽